Medicine and Dentistry
Toxicity
100%
Malignant Neoplasm
100%
Anthracycline
100%
Heart Protection
100%
Systematic Review
100%
Cardiotoxicity
75%
Randomized Controlled Trial
62%
Doxorubicin
62%
Cohort Analysis
50%
Cardiac Marker
50%
Heart Injury
37%
Continuous Infusion
37%
Cost-Effectiveness Analysis
37%
Effectiveness Study
25%
Dexrazoxane
25%
Brain Natriuretic Peptide
25%
Diseases
12%
Heart Function
12%
Cardiac Troponin
12%
Atrial Natriuretic Factor
12%
Lipid Peroxide
12%
Sequela
12%
Event Free Survival
12%
Coenzyme Q10
12%
Antileukemic Agent
12%
Liposomal Daunorubicin
12%
Amino Terminal Sequence
12%
Childhood Cancer
12%
Acute Lymphoblastic Leukemia
12%
Infusion
12%
Non-Hodgkin Lymphoma
12%
Troponin T
12%
Heart Performance
12%
Health Care Cost
12%
Toddlers
12%
Carnitine
12%
Nursing and Health Professions
Systematic Review
100%
Malignant Neoplasm
100%
Toxicity
100%
Anthracycline
100%
Heart Protection
100%
Cardiotoxicity
75%
Doxil
62%
Cohort Analysis
50%
Cost Effectiveness Analysis
37%
Heart Injury
37%
Continuous Infusion
37%
Razoxane
25%
Brain Natriuretic Peptide
25%
Toddlers
12%
Ubidecarenone
12%
Nonhodgkin Lymphoma
12%
Lipid Blood Level
12%
Disease
12%
Atrial Natriuretic Factor
12%
Carnitine
12%
Lipid Peroxide
12%
Acute Lymphoblastic Leukemia
12%
Antileukemic Agent
12%
Event Free Survival
12%
Troponin T
12%
Infusion
12%
Childhood Cancer
12%
Daunorubicin
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Toxicity
100%
Anthracycline
100%
Cardiotoxicity
75%
Doxorubicin
62%
Randomized Controlled Trial
62%
Cohort Study
50%
Heart Injury
37%
Effectiveness Study
25%
Brain Natriuretic Peptide
25%
Razoxane
25%
Daunorubicin
12%
Disease
12%
Acute Lymphoblastic Leukemia
12%
Atrial Natriuretic Factor
12%
Carnitine
12%
Lipid Peroxide
12%
Nonhodgkin Lymphoma
12%
Event Free Survival
12%
Troponin T
12%
Antileukemic Agent
12%
Ubidecarenone
12%
Childhood Cancer
12%
INIS
reviews
100%
cancer
100%
children
100%
toxicity
100%
doxorubicin
41%
cost
33%
infusion
33%
peptides
25%
levels
16%
damage
16%
therapy
16%
monitoring
16%
inclusions
16%
data
8%
performance
8%
increasing
8%
injuries
8%
management
8%
interventions
8%
surveillance
8%
brain
8%
standardization
8%
leukemia
8%
lipids
8%
bibliographies
8%
peroxides
8%
lymphomas
8%
coenzymes
8%
carnitine
8%